Liangyu Lin
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 5%
- Genetics top 2%
- Cancer Research top 5%
- Topics
- Mesenchymal stem cell research (10 papers)Immune cells in cancer (9 papers)Cancer Cells and Metastasis (5 papers)
- Cited by
- GeneticsCancer ResearchImmunology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Reviews Drug Discovery
- Partner nations
- ChinaItalyUnited States
In The Last Decade
Liangyu Lin
23 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 928
- Oncology 748
- Immunology 700
- Genetics 578
- Cancer Research 533
Countries citing papers authored by Liangyu Lin
This map shows the geographic impact of Liangyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangyu Lin more than expected).
Fields of papers citing papers by Liangyu Lin
This network shows the impact of papers produced by Liangyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangyu Lin. The network helps show where Liangyu Lin may publish in the future.
Co-authorship network of co-authors of Liangyu Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Liangyu Lin. A scholar is included among the top collaborators of Liangyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangyu Lin. Liangyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 24 | |
| 4 | 12 | |
| 5 | 14 | |
| 6 | 11 | |
| 7 | 58 | |
| 8 | 43 | |
| 9 | 77 | |
| 10 | 141 | |
| 11 | 88 | |
| 12 | 72 | |
| 13 | 71 | |
| 14 | 137 | |
| 15 | Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targetsbreakdown → | 373 |
| 16 | 185 | |
| 17 | 130 | |
| 18 | 82 | |
| 19 | 59 | |
| 20 | 40 |
About Liangyu Lin
Liangyu Lin is a scholar working on Genetics, Immunology and Oncology, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (10 papers), Immune cells in cancer (9 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Genetics (578 citations), Cancer Research (533 citations) and Immunology (700 citations). Liangyu Lin has collaborated with scholars based in China, Italy and United States. Frequent co-authors include Yufang Shi, Ying Wang, Liming Du, Pengfei Yu, Guohong Hu, Yin Huang, Xueqian Zhuang, Fei Chen, Yu Sun and Yuping Han. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.